QMSR-820.10 | Requirements for a Quality Management System - ISO 13485:2016 Sections 4-8 incorporation (§820.10) | 32 |
QMSR-820.15 | Clarification of concepts (§820.15) | 1 |
QMSR-820.1_3_7 | Scope, definitions and incorporation by reference (§§820.1, 820.3, 820.7) | 0 |
QMSR-820.35 | Control of records - record retention, audit trail, UDI, medical-device reporting (§820.35) | 1 |
QMSR-820.45 | Device labelling and packaging controls (§820.45) | 50 |
QMSR-Coord-ISO13485-MDR-IVDR-Part11 | Coordination with ISO 13485:2016, EU MDR/IVDR, FDA Part 11, Cybersecurity Guidance | 3 |
QMSR-ISO13485-Sec5 | Management responsibility (ISO 13485:2016 Section 5 - incorporated via §820.10) | 79 |
QMSR-ISO13485-Sec6 | Resource management (ISO 13485:2016 Section 6 - incorporated via §820.10) | 13 |
QMSR-ISO13485-Sec7_DesignControls | Product realization - Design and Development controls (ISO 13485:2016 Section 7.3) | 10 |
QMSR-ISO13485-Sec7_Purchasing | Purchasing controls + supplier management (ISO 13485:2016 Section 7.4) | 41 |
QMSR-ISO13485-Sec8 | Measurement, analysis and improvement (ISO 13485:2016 Section 8) | 19 |
QMSR-Status | FDA QMSR - corpus status, enforcement landscape, future evolution | 0 |
QMSR-Transition | Transition from prior QSR + 2 February 2026 application + FDA inspection approach | 0 |